+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Prostate Cancer Drugs Market Research Reports

From
Benign Prostatic Hyperplasia Treatment Global Market Report 2025 - Product Thumbnail Image

Benign Prostatic Hyperplasia Treatment Global Market Report 2025

  • Report
  • January 2025
  • 175 Pages
  • Global
From
Capecitabine - Global Strategic Business Report - Product Thumbnail Image

Capecitabine - Global Strategic Business Report

  • Report
  • December 2025
  • 220 Pages
  • Global
From
From
Leuprolide Acetate - Global Strategic Business Report - Product Thumbnail Image

Leuprolide Acetate - Global Strategic Business Report

  • Report
  • December 2025
  • 282 Pages
  • Global
From
From
From
From
Leuprolide Acetate Market 2025-2029 - Product Thumbnail Image

Leuprolide Acetate Market 2025-2029

  • Report
  • June 2025
  • 198 Pages
  • Global
From
From
From
From
From
From
Metastatic Castration Resistant Prostate Cancer Market - Product Thumbnail Image

Metastatic Castration Resistant Prostate Cancer Market

  • Report
  • January 2025
  • 250 Pages
  • Global
From
Metastatic Prostate Cancer Drug Pipeline Analysis Report 2025 - Product Thumbnail Image

Metastatic Prostate Cancer Drug Pipeline Analysis Report 2025

  • Drug Pipelines
  • June 2025
  • 200 Pages
  • Global
From
From
Loading Indicator

The Prostate Cancer Drugs market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs used to treat prostate cancer. Prostate cancer is the most common cancer in men, and the drugs used to treat it can vary depending on the stage and severity of the disease. Common treatments include hormone therapy, chemotherapy, and radiation therapy. The Prostate Cancer Drugs market is highly competitive, with many companies vying for market share. Major players in the market include Astellas Pharma, Bayer, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, and Sanofi. These companies are constantly researching and developing new drugs to treat prostate cancer, as well as improving existing treatments. Show Less Read more